Species differences in localization of cardiac cAMP-phosphodiesterase activity: A cytochemical study

Molecular and Cellular Biochemistry

Volumn 173, Issue 1-2, 1997, Pages 183-188

  Okruhlicová, L'Udmila ^a   Tribulová, Narcisa ^a   Styk, Ján ^a   Eckly, Anita ^b   Lugnier, Ciaire ^b   Slezák, Ján ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cytochemistry; Dog; Myocardium; Phosphodiesterase; Rat

Indexed keywords

CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; LEAD;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOCHEMISTRY; DOG; ENZYME SUBSTRATE; FEMALE; HEART; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HEART VENTRICLE; MALE; NONHUMAN; PROTEIN LOCALIZATION; RAT; SARCOPLASMIC RETICULUM; SPECIES DIFFERENCE; TISSUE DISTRIBUTION; TISSUE FIXATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CYCLIC AMP; DOGS; HISTOCYTOCHEMISTRY; MYOCARDIUM; RATS; RATS, WISTAR; SARCOLEMMA; SARCOPLASMIC RETICULUM; SPECIES SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS;

EID: 0030860222     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006845513962     Document Type: Article

References (34)

1. Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11: 150-155, 1990
2. Manganiello VC: Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases. J Mol Cell Cardiol 19: 1037-1040, 1987
3. Weishaar RE, Burrows SD, Kobylarz DC, Quade MM, Evans DB: Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Biochem Pharmacol 35: 787-800, 1986
4. Weishaar RE, Kobylarz-Singer DC, Steffen RP, Kaplan HR: Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility. Circ Res 61: 539-547, 1987a
5. Lugnier C, Schini VB: Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells. Biochem Pharmacol 39: 75-841, 1990
6. Ivorra MD, Le Bec A, Lugnier C: Characterization of membrane-bound cyclic-nucleotide phosphodiesterases from bovine aortic smooth muscle. J Cardiovasc Pharmacol 19: 532-540, 1992
7. Lugnier C, Muller B, Le Bec A, Beaudri C, Rousseau E: Cyclic nucleotide phosphodiesterase in canine and human cardiac microsomal fractions. J Pharmacol Exp Ther 265: 1142-1151, 1993
8. Komas N, Lugnier C, Stoclet JC: Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 104: 495-503, 1991
9. Weishaar RE, Quade MM, Sehenden JA, Evans B: Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics. J Cyclic Nucleotide Protein Phosphor Res 10: 551-564, 1985
10. Alvarez R, Banerjee GL, Bruno JJ, Jones GL, Lüttschwager K, Strosberg AM, Venuti MC: A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties. Mol Pharmacol 29: 554-560, 1986
11. Morgan JP, Gwathmey JK, Defeo TT, Morgan KG: The effects of amrinone and related drugs on intracellular calcium in isolated mammalian cardiac and vascular smooth muscle. Circulation 73 (Suppl. III): III65-III77, 1986
12. Muller B, Stoclet JC, Lugnier C: Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles. Eur J Pharmacol 225: 263-272, 1992
13. Katano Y, Endoh M: Differential effects of RO 20-1724 and isobutylmethyl-xantine on the basal force of contraction and beta-adrenoceptors-mediated response in the rat ventricular myocardium. Biochem Biophys Res Commun 167: 123-128, 1990
14. Shahid M, Nicholson CD: Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: Positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram. Naunyn-Schmied Arch Pharmacol 342: 698-704, 1990
15. Alousi A, Farah AK: Letter to the Editor. Circ Res 46: 887-888, 1980
16. Kobylarz DC, Steffen RP, Weishaar RE, Evans DB: Relationship between inhibition of ventricular peak III phosphodiesterase (PDE) and the in vivo cardiotonic effect of CI-914 in several species [Abstract]. Pharmacologist 27: 683-689, 1985
17. Weishaar RE, Kobylarz-Singer DC, Kaplan HR: Subclasses of cyclic AMP phosphodiesterase in cardiac muscle. J Mol Cell Cardiol 16: 1025-1036, 1987b
18. Komas N, Lugnier C, Stoclet JC: Pharmacological characterization of membrane-bound forms of cAMP phosphodiesterase from cardiac tissue. J Mol Cell Cardiol 22 (Suppl. 4): S32-S38, 1990
19. Vrbjar N, Le Bec A, Lugnier C: Localization of cyclic nucleotide phosphodiesterase III and IV in purified canine cardiac sarcolemma [Abstract]. J Mol Cell Cardiol 26 XII: 5.7, 1994
20. Sugimura K, Mizutani A. Electron-microscopic cytochemical study of cyclic nucleotide phosphodiesterase in rat brain. Histochemistry 55: 97-105, 1978
21. Schulze W: Methods for histochemical localization of adenylate cyclase and guanylate cyclase in heart membrane. In: NS Dhalla (ed). Methods Studying Cardiac Membranes. Vol. II. Florida: CRS Press, Inc Boca Raton, 1984, pp 83-97
22. Slezak J, Geller SA: Cytochemical demonstration of adenylate cyclase in cardiac muscle. Effect of dimethylsulfoxide. J Histochem Cytochem 27: 774-781, 1979
23. Slezak J, Tribulova N: Subcellular localization of adenylate cyclase and guanylate cyclase in heart muscle cells. Histochem J 16: 380-382, 1984
24. Okruhlicova L, Slezak J: The effect of calmodulin inhibitors of adenylate cyclase system. Physiol Bohemoslov 39: 240-244, 1990
25. Shahid M, Wilson M, Nicholson CD, Marshall RJ: Species-dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardium. J Pharm Pharmacol 42: 282-288, 1990
26. Okruhlicová L, Tribulová N, Eckly A, Lugnier C, Slezak J: Cytochemical distribution of cyclic AMP-dependent 3,5-nucleotide phosphodiesterase in the rat myocardium. Histochem J 28: 165-172, 1996
27. Endo M: Calcium release from the SR. Physiol Rev 57: 71-108, 1977
28. Fabiato A: Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 245: C1-C14, 1983
29. Poeggel G, Luppa H, Schmidt A: Histochemistry of cyclic nucleotide phosphodiesterase in nervous tissue III. Enzyme cytochemical investigations. Acta Histochem Cytochem 21: 473-480, 1988
30. Prigent AF, Fougier S, Nemoz G, Anger G, Pacheco H, Lugnier C, Le Bec A, Stoclet JC: Comparison of cyclic nucleotide phosphodiesterase isoforms from rat heart and bovine aorta: Separation and inhibition by selective reference phosphodiesterase inhibitors. Biochem Pharmacol 37: 3671-3681, 1988
31. Tribulová N, Slezák J, Ravingerová T, Pavlíkova D, Okruhlicová B: Cytochemical approaches to the conducting system of the heart in normal and pathological conditions. [Abstract] Histochem J 24: 292, 1992
32. Tribulová N, Okruhlicová L',Ziegelhöffer B, Slezák J: Ultrastructure and cytochemistry of the developing rat myocardium in normal and ischemic conditions. In: Abstracts: 'Progress in Basic, Applied and Diagnostic Histochemistry', Olomouc, 1994a, p 94
33. Tribulova N, Ziegelhoffer B, Slezak J: Histochemical characterization of the developing rat myocardium in physiologic and ischemic conditions. In: S Hanusho, K Kjeldsen (eds). Proceedings of XV European Section Meeting of the International Society for Heart Research 1994b: pp 711-715
34. Borgers M, Thone F: Species differences in adenosine metabolic sites in the heart. Histochem J 24: 445-452, 1992